Results 1 to 10 of about 843,286 (322)

Usefulness of prostate specific antigen density in detecting prostate carcinoma: A hospital-based study in patients with prostate biopsies

Journal of Pathology of Nepal, 2022
Background: Prostate-specific antigen density has been suggested to enhance the diagnostic efficacy of serum prostate-specific antigen alone in detecting prostate cancer, thereby reducing unnecessary biopsies and associated morbidities.
Reshmi Shrestha, Shova Kunwar, Suman Gurung, Anjana Nuri Pokharel   +3 more
doaj   +1 more source

Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients

BMC Medicine, 2021
Background Prostate-specific antigen (PSA) is a commonly used test to detect prostate cancer. Attention has mostly focused on the use of PSA in screening asymptomatic patients, but the diagnostic accuracy of PSA for prostate cancer in patients with ...
S. Merriel, L. Pocock, Emma Gilbert, S. Creavin, F. Walter, A. Spencer, W. Hamilton   +6 more
semanticscholar   +1 more source

Clinical application of free/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0–25.0 ng ml-1 in Western China

Asian Journal of Andrology, 2022
The goal of this study was to investigate the clinical application of free/total prostate-specific antigen (F/T PSA) ratio, considering the new broad serum total PSA (T-PSA) “gray zone” of 2.0–25.0 ng ml−1 in differential diagnosis of prostate cancer ...
Xue-Dan Gao, Qiang Miao, Jun-Long Zhang, Jian-Zhao Zhai, Xue-Mei Gui, Yi-Han Cai, Qian Niu, Bei Cai   +7 more
doaj   +1 more source

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY)

Journal of Urology, 2021
Purpose: Prostate specific membrane antigen-targeted positron emission tomography/computerized tomography has the potential to improve the detection and localization of prostate cancer.
K. Pienta, M. Gorin, S. Rowe, P. Carroll, F. Pouliot, S. Probst, Lawrence Saperstein, M. Preston, A. Alva, Akash Patnaik, J. Durack, N. Stambler, Tess E. Lin, J. Jensen, Vivien Wong, B. Siegel, M. Morris   +16 more
semanticscholar   +1 more source

Body mass index in relation to prostate-specific antigen-related parameters

BMC Urology, 2021
Background Only a few previous studies conducted to assess the association between body mass index (BMI) and prostate-specific antigen (PSA) related parameters have taken prostate volume (PV) and blood volume (BV) into consideration.
Dandan Lin, Ting Liu, Luling Chen, Zongtao Chen   +3 more
doaj   +1 more source

Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - a systematic review

Oncology Reviews, 2020
Prostate-specific antigen velocity (PSAV) is widely used to detect PC and predict its progression. In this study, we qualitatively synthesized the currently available evidence from published studies regarding the PSAV role in PC.
Arslaan Javaeed, Sanniya Khan Ghauri, Abdellatif Ibrahim, Mohamed Fahmy Doheim   +3 more
doaj   +1 more source

The Efficiency of the Serum Prostate Specific Antigen Levels in Diagnosing Prostatic Enlargements [PDF]

Journal of Clinical and Diagnostic Research, 2013
Background: The objective of this study was to evaluate the serum PSA levels in patients presenting with enlarged prostate and to evaluate the efficiency of serum PSA to diagnose and differentiate benign and malignant enlargements.
Ingle SP, Ingle Ramona, Sukesh
doaj   +1 more source

Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging

Journal of Nuclear Medicine, 2021
cancer is the common cancer diagnosis in men in the United and a leading cause of cancer-related morbidity and mortality ( ). It can exist along a wide spectrum of aggressiveness and severity, from indolent, very-low-risk, localized prostate cancer to ...
H. Jadvar, J. Calais, S. Fanti, F. Feng, Kirsten L. Greene, J. Gulley, M. Hofman, B. Koontz, D. Lin, M. Morris, S. Rowe, T. Royce, S. Salami, B. Savir-Baruch, S. Srinivas, T. Hope   +15 more
semanticscholar   +1 more source

The use of prostate specific antigen density to predict clinically significant prostate cancer

Scientific Reports, 2020
The purpose of this study was to assess the predictive value of prostate specific antigen density (PSAD) for detection of clinically significant prostate cancer in men undergoing systematic transrectal ultrasound (TRUS)-guided prostate biopsy.
I. Yusim, Muhammad Krenawi, E. Mazor, V. Novack, N. Mabjeesh   +4 more
semanticscholar   +1 more source

CUT-OFF POINT OF PSA AND PSA DENSITY IN PROSTATE CANCER SUSPECTED PATIENTS

Jurnal Urologi Indonesia, 2016
Objective: In Hasan Sadikin General Hospital Bandung prostate biopsy is recommended for patients with prostate specific antigen (PSA) levels above 10 ng/mL or PSA density (PSAD) above 0.15 if PSA in between 4–10 ng/mL.
Daniel Simanjuntak, Ferry Safriadi
doaj   +1 more source